Home
ImmunityBio IBRX paid Continental Strategy $60K for lobbying in Q4 2025 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q4 2025
- Stock
- ImmunityBio IBRX
- Client
- Immunitybio
- Reported
- 26/01/19
First lobbying report
What else happened in ImmunityBio around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Immunitybio's other lobbying reports
- Immunitybio
LobbyingImmunityBio
LobbyingImmunityBio
IBRX
Under $5,000
Under $5,000
Reported 07/19
for Q2
- Immunitybio
LobbyingImmunityBio
LobbyingImmunityBio
IBRX
$60K
$60K
Reported 04/18
for Q1